FDA Guidance Outlines a Framework for the Evaluation of Long-Term Neurodevelopmental Safety Studies in Neonatal Product Development
FDA Law Blog
OCTOBER 28, 2024
The protocol should also include a plan for clinical referral and support services if any developmental problems are identified during the follow-up. raw scores, standardized norm-referenced scores), some of which might present floor or ceiling effects; and ensuring that selected COAs have demonstrated reliability across demographic groups.
Let's personalize your content